Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for SARS-CoV-2 Infection.

NCT04817371 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT04817371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04817371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for SARS-CoV-2 Infection.
Lead sponsor
Hopital Foch
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2021
Completion date
September 30, 2022
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19